Outcome after induction chemotherapy for older patients with acute myeloid leukemia is not improved with mitoxantrone and etoposide compared to cytarabine and daunorubicin: a Southwest Oncology Group study
Blood (2002) 100 (12): 3869–3876.
Currently there are no citedby results. Try again later.
